Practical side effect management strategies reduce discontinuation rates
Xu Q, Pan J, Yu J, Liu X, Liu L, Zuo X, Wu P, Deng H, Zhang J, Ji A
[6] [7] This brief duration has led to the development of GLP-1 receptor agonists (such as semaglutide and liraglutide), which are DPP-4-resistant analogues with prolonged half-lives, and DPP-4 inhibitors as therapeutic agents for type 2 diabetes
How soon after a type 2 diabetes diagnosis should you consider starting a GLP-1
Medicare helps cover the care
Provider visits are billed through insurance or our self pay options